Display options
Cite
Cho MK. Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Med J. 2018;54(3):153-158doi: 10.4068/cmj.2018.54.3.153.
Cho, M. K. (2018). Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam medical journal, 54(3), 153-158. https://doi.org/10.4068/cmj.2018.54.3.153
Cho, Moon Kyoung. "Use of Combined Oral Contraceptives in Perimenopausal Women." Chonnam medical journal vol. 54,3 (2018): 153-158. doi: https://doi.org/10.4068/cmj.2018.54.3.153
Cho MK. Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Med J. 2018 Sep;54(3):153-158. doi: 10.4068/cmj.2018.54.3.153. Epub 2018 Sep 27. PMID: 30288370; PMCID: PMC6165915.
Copy Download .nbib Format: NLM
Share it on

Chonnam Med J. 2018 Sep;54(3):153-158. doi: 10.4068/cmj.2018.54.3.153. Epub 2018 Sep 27.

Use of Combined Oral Contraceptives in Perimenopausal Women.

Chonnam medical journal

Moon Kyoung Cho

Affiliations

  1. Department of Obstetrics and Gynecology, Research Institute of Medical Sciences, Chonnam National University Medical School, Gwangju, Korea.

PMID: 30288370 PMCID: PMC6165915 DOI: 10.4068/cmj.2018.54.3.153

Abstract

While perimenopausal women have low fecundity, they are still capable of becoming pregnant and the majority of pregnancies occurring during perimenopause are unintended pregnancies. Therefore, even during perimenopause, contraception must be used if unintended pregnancies are to be avoided. However, many perimenopausal women and healthcare providers believe that older people should not take combined oral contraceptives (COC) because doing so may be dangerous. However, to date, there is no evidence that taking COC presents an increased risk of cardiovascular events or breast cancer for middle-aged women as compared to other age groups, and in their recommendations, the Centers for Disease Control and Prevention (CDC) also do not list age itself as a contraindication for COC. Perimenopausal women often experience menstrual irregularity, heavy menstrual bleeding, and vasomotor symptoms. Taking COCs can help control these symptoms and significantly reduce the risk of ovarian cancer, endometrial cancer, and colorectal cancer. The objective of the present review is to examine the usage methods of COC among perimenopausal women and the health issues that may arise from taking COC in perimenopausal women.

Keywords: Contraceptives, Oral, Combined; Female; Perimenopause; Risk Factors

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT: None declared.

References

  1. Obstet Gynecol. 2011 Apr;117(4):777-87 - PubMed
  2. N Engl J Med. 2002 Jun 27;346(26):2025-32 - PubMed
  3. Lancet. 1999 May 1;353(9163):1481-4 - PubMed
  4. Cochrane Database Syst Rev. 2014 Mar 03;(3):CD010813 - PubMed
  5. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004143 - PubMed
  6. Contraception. 2000 Feb;61(2):77-82 - PubMed
  7. Eur J Contracept Reprod Health Care. 2012 Dec;17(6):402-14 - PubMed
  8. Korean Circ J. 2009 Nov;39(11):467-76 - PubMed
  9. Obstet Gynecol. 2012 Nov;120(5):1239-42 - PubMed
  10. Womens Health. 1997 Summer;3(2):103-20 - PubMed
  11. Am J Public Health. 1993 Jan;83(1):100-2 - PubMed
  12. Obstet Gynecol. 2013 Aug;122(2 Pt 1):380-9 - PubMed
  13. Maturitas. 2006 May 20;54(2):176-80 - PubMed
  14. BMJ. 2013 Sep 12;347:f5298 - PubMed
  15. Anim Reprod Sci. 2011 Apr;124(3-4):229-36 - PubMed
  16. N Engl J Med. 2008 Mar 20;358(12):1262-70 - PubMed
  17. Lancet Oncol. 2015 Sep;16(9):1061-1070 - PubMed
  18. Lancet. 2008 Jan 26;371(9609):303-14 - PubMed
  19. Maturitas. 2015 Nov;82(3):266-70 - PubMed
  20. Maturitas. 2009 Jul 20;63(3):204-12 - PubMed
  21. Contraception. 2013 May;87(5):567-75 - PubMed
  22. Contraception. 2005 Mar;71(3):183-7 - PubMed
  23. Hum Reprod Update. 2009 Sep-Oct;15(5):489-98 - PubMed
  24. Aust N Z J Obstet Gynaecol. 1991 Feb;31(1):66-70 - PubMed
  25. Headache. 2007 Jan;47(1):27-37 - PubMed
  26. Fertil Steril. 1996 Jul;66(1):101-4 - PubMed
  27. Maturitas. 2016 May;87:79-83 - PubMed
  28. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004695 - PubMed
  29. MMWR Recomm Rep. 2016 Jul 29;65(4):1-66 - PubMed
  30. Ann Intern Med. 2012 May 1;156(9):635-48 - PubMed
  31. Obstet Gynecol. 2000 Dec;96(6):913-20 - PubMed
  32. Menopause. 2001 Jul-Aug;8(4):286-9 - PubMed
  33. Contraception. 2003 Jan;67(1):9-13 - PubMed
  34. Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1931-43 - PubMed
  35. Emerg (Tehran). 2014 Winter;2(1):1-11 - PubMed
  36. MMWR Recomm Rep. 2016 Jul 29;65(3):1-103 - PubMed
  37. Contraception. 2012 May;85(5):437-45 - PubMed
  38. Epidemiology. 2008 Mar;19(2):237-43 - PubMed
  39. Contraception. 2013 Oct;88(4):523-31 - PubMed
  40. Menopause. 2014 Oct;21(10):1038-62 - PubMed
  41. Cochrane Database Syst Rev. 2013 Aug 01;(8):CD003989 - PubMed
  42. Hum Reprod. 2002 May;17(5):1399-403 - PubMed
  43. Contraception. 2012 Aug;86(2):96-101 - PubMed
  44. Cochrane Database Syst Rev. 2014 Jul 29;(7):CD004695 - PubMed
  45. Int J Fertil. 1985;30(1):15, 18-28 - PubMed
  46. Lancet. 1996 Jun 22;347(9017):1713-27 - PubMed
  47. J Thromb Haemost. 2011 Jan;9(1):85-91 - PubMed
  48. J Clin Endocrinol Metab. 2012 Apr;97(4):1159-68 - PubMed
  49. Cochrane Database Syst Rev. 2015 Aug 27;(8):CD011054 - PubMed
  50. Climacteric. 2016 Dec;19(6):526-534 - PubMed
  51. Maturitas. 2013 Nov;76(3):235-42 - PubMed

Publication Types